Circle Pharma Appoints Stephen Kelsey, MB ChB, MD, to its Board of Directors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a company focused on developing macrocycle therapeutics against targets previously considered to be undruggable, has appointed Stephen Kelsey as an independent member of its Board of Directors. Dr. Kelsey has extensive experience in oncology clinical development. He currently serves as president, head of research...
